Little Green Pharma Ltd

AU:LGP Australia Drug Manufacturers - Specialty & Generic
Market Cap
$18.93 Million
AU$30.56 Million AUD
Market Cap Rank
#26979 Global
#651 in Australia
Share Price
AU$0.10
Change (1 day)
+0.00%
52-Week Range
AU$0.10 - AU$0.14
All Time High
AU$0.94
About

Little Green Pharma Ltd engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally. The company offers dried cannabis flower medicines and cannabis oils. Little Green Pharma Ltd was incorporated in 2016 and is based in West Perth, Australia.

Little Green Pharma Ltd - Asset Resilience Ratio

Latest as of September 2025: 2.36%

Little Green Pharma Ltd (LGP) has an Asset Resilience Ratio of 2.36% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
AU$2.30 Million
Cash + Short-term Investments
Total Assets
AU$97.60 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2018–2025)

This chart shows how Little Green Pharma Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Little Green Pharma Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$2.30 Million 2.36%
Short-term Investments AU$0.00 0%
Total Liquid Assets AU$2.30 Million 2.36%

Asset Resilience Insights

  • Limited Liquidity: Little Green Pharma Ltd maintains only 2.36% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Little Green Pharma Ltd Industry Peers by Asset Resilience Ratio

Compare Little Green Pharma Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
Drug Manufacturers - Specialty & Generic -0.02%
Kamada
NASDAQ:KMDA
Drug Manufacturers - Specialty & Generic 21.63%
Dongwha Pharm.Co.Ltd
KO:000020
Drug Manufacturers - Specialty & Generic 1.92%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%
Kotra Industries Bhd
KLSE:0002
Drug Manufacturers - Specialty & Generic 9.82%
Yuyu Pharma Inc
KO:000227
Drug Manufacturers - Specialty & Generic 1.74%

Annual Asset Resilience Ratio for Little Green Pharma Ltd (2018–2025)

The table below shows the annual Asset Resilience Ratio data for Little Green Pharma Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-06-30 2.47% AU$2.38 Million AU$96.12 Million -3.29pp
2024-06-30 5.76% AU$4.97 Million AU$86.38 Million -6.82pp
2023-06-30 12.57% AU$12.40 Million AU$98.62 Million -8.36pp
2022-06-30 20.94% AU$20.09 Million AU$95.95 Million -15.35pp
2021-06-30 36.28% AU$40.27 Million AU$110.99 Million +10.23pp
2020-06-30 26.05% AU$4.27 Million AU$16.40 Million +22.77pp
2019-06-30 3.28% AU$510.29K AU$15.57 Million -33.38pp
2018-06-30 36.65% AU$1.47 Million AU$4.02 Million --
pp = percentage points